Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05990439 · ClinicalTrials.gov registry record · NA
Baby-Feed Web Application for Infant Caregivers to Improve Diets and Weight Gain
A NA study of Obesity, Childhood, sponsored by Florida International University.
- Completed
- Registry status
- NA
- Development phase
- 155
- Enrollment target
- 1
- Study location
NCT05990439: Completed NA study of Obesity, Childhood, sponsored by Florida International University.
NCT05990439 is a NA study of Obesity, Childhood that has completed, run by Florida International University. The registered enrollment target is 155 participants, below the 341-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05990439, a NA study of Obesity, Childhood, has completed, sponsored by Florida International University.
- COMPLETED
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the Baby-Feed web platform among 160 parents with infants aged 1-3 months at the time of enrollment and follow them through their 9-month well-child visit (about a total of 6 months) using a mixed-methods approach (randomized control trial with qualitative interviews).
Primary Outcome
It will be analyzed from the responses to the infant FFQ using the Diet Quality Index Score (DQIS)
Conditions Studied
Interventions
- BEHAVIORAL Baby-Feed
- BEHAVIORAL Limited access to the Baby-Feed web application
Study Locations (1)
Florida
- Florida International University - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2025-08-01 |
| Phase | NA |
What the finished NCT05990439 record still lists
NCT05990439 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 341-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Obesity, Childhood appearing as the primary indexed condition, and to 2 interventions - of which Baby-Feed is the first listed.
NCT05990439 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05990439 about?
NCT05990439 is a clinical study titled "Baby-Feed Web Application for Infant Caregivers to Improve Diets and Weight Gain". This study will test the Baby-Feed web platform among 160 parents with infants aged 1-3 months at the time of enrollment and follow them through their 9-month well-child visit (about a total of 6 months) using a mixed-methods approach (randomized control trial with qualitative interviews).
What is the current status of trial NCT05990439?
This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2024-04-01. Estimated completion is 2025-08-01.
What conditions does trial NCT05990439 study?
This clinical trial studies the following conditions: Obesity, Childhood.
What interventions are being tested in trial NCT05990439?
The interventions under investigation include: Baby-Feed (BEHAVIORAL), Limited access to the Baby-Feed web application (BEHAVIORAL).
Who is sponsoring clinical trial NCT05990439?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05990439 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity, Childhood
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05990439's enrollment target sits among peer trials
155 27th of 53 higher than 27 of 53 other Obesity, Childhood trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity, Childhood trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Increasing Food Literacy in Preschoolers to Reduce Obesity Risk
RECRUITING · NA
-
A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children
RECRUITING · NA
-
Intervention INC: An Interactive Family-centered mHealth Tool to Reduce Obesity Risk in Urban Minority Preadolescents
RECRUITING · NA
-
Food Genetics Behavior Study
RECRUITING · NA
-
Whole Foods for Teens: A Pilot Dietary Intervention to Reduce Body Adiposity in Adolescents With Obesity
RECRUITING · NA
-
Family, Responsibility, Education, Support, and Health for Food Responsiveness
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI